EASYGEN, an EU-funded research consortium, led by Fresenius SE & Co. KGaA, brings together clinicians, scientists, engineers and experts from accross europe to revolutionize CAR-T therapy.The mission: to make CAR-T treatments faster, more affordable and more accessible - directly in hospitals.